Current Medicinal Chemistry
Title:Editorial: Molecular Scenarios Behind Infectious Diseases
Volume: 24 Issue: 36
Author(s): Rita Berisio, Flavia Squeglia and Alessia Ruggiero
Affiliation:
Export Options
About this article
Cite this article as:
Berisio Rita , Squeglia Flavia and Ruggiero Alessia , Editorial: Molecular Scenarios Behind Infectious Diseases, Current Medicinal Chemistry 2017; 24 (36) . https://dx.doi.org/10.2174/092986732436171124165140
DOI https://dx.doi.org/10.2174/092986732436171124165140 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
24
4
1
1
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
The Potential of Natural Diterpenes Against Tuberculosis: An Updated Review
Current Pharmaceutical Design Potential Use of Dendritic Cells for Anti-Atherosclerotic Therapy
Current Pharmaceutical Design Structure-based Discovery of Novel Antibacterials
Anti-Infective Agents in Medicinal Chemistry Adjunctive Immunotherapeutic Efficacy of N-Formylated Internal Peptide of Mycobacterial Glutamine Synthetase in Mouse Model of Tuberculosis
Protein & Peptide Letters Meet Our Editorial Board Member
Drug Delivery Letters Contrast-enhanced Ultrasound for Diagnosis of Renal Cystic Mass
Current Medical Imaging The Relevance of New Drug Combinations for Modern Tuberculosis Treatment - A Patent Perspective
Recent Patents on Anti-Infective Drug Discovery Zebrafish Model in Drug Safety Assessment
Current Pharmaceutical Design Mode Action Prediction of Butein as Antibacterial Oral Pathogen against <i>Enterococcus faecalis</i> ATCC 29212 and an Inhibitor of MurA Enzyme: In Vitro and In Silico Study
Letters in Drug Design & Discovery Advances in Mycobacterial Isocitrate Lyase Targeting and Inhibitors
Current Medicinal Chemistry Pulmonary Manifestations of Rheumatoid Arthritis, Psoriatic Arthritis and Peripheral Spondyloarthritis: Prevalence, Diagnostic Approach and Treatment Options
Current Rheumatology Reviews Hybrid Imaging in Evaluation of Abdominal Sarcoidosis
Current Medical Imaging Protein Secretome Analysis of Evolving and Responding Tumor Ecosystems
Current Proteomics In Vitro Drug-Drug Interaction Potential of Sulfoxide and/or Sulfone Metabolites of Albendazole, Triclabendazole , Aldicarb, Methiocarb, Montelukast and Ziprasidone
Drug Metabolism Letters Immunology of AIDS Virus and Mycobacterial Co-Infection
Current HIV Research Anti-mycobacterial Activity of 22 Iranian Endemic or Rare Plant Extracts Against Multi-drug and Extensively Drug-resistant <i>Mycobacterium tuberculosis</i>
Combinatorial Chemistry & High Throughput Screening Enzymes with Phosphotriesterase and Lactonase Activities in Archaea
Current Chemical Biology Is Targeting microRNAs the Philosopher’s Stone for Vascular Disease?
Current Vascular Pharmacology Evaluation of the Agreement Between the Tissue Sample and Bronchoalveolar Lavage (BAL) Fluid in the Diagnosis of Tuberculosis in Patients with Anthracosis
Current Respiratory Medicine Reviews Mycobacterial tuberculosis Enzyme Targets and their Inhibitors
Current Topics in Medicinal Chemistry